Pharmaceutical Patent Attorneys

Kevin Buckley is a pharmaceutical patent attorney who has represented small molecule pharmaceutical, biopharmaceutical and specialty chemical innovators for more than 20 years. His experience has provided valuable insight into solving complex legal problems related to the intersection of patent protection, commercialization strategy, program funding strategy, product marketing, securing supply chains, securing CMC and manufacturing protections, distribution, reimbursement, obtaining FDA approvals, and maintaining FDA regulatory compliance. His experience includes:

Obtaining international "Orange Book-listable" pharmaceutical and biopharmaceutical patents.
Drafting legal opinions related to patentability, patent infringement, non-infringement, patent validity, and safe harbor, for both branded and generic clients.
Helping obtain regulatory approvals for therapeutic products throughout the world including in the United States FDA, European EMA, Japan PMDA and China FDA.
Securing private investment and government funding for pharmaceutical and biopharmaceutical research and development.
In- and out-licensing pharmaceutical, biopharmaceutical and specialty chemical technology and IP.
Litigating matters for pharmaceutical industry clients in federal courts.

The patent attorneys, engineers, scientists, and patent agents at Torrey Pines Law Group have worked in a variety of pharmaceutical industries, both branded and generic, and have assisted with commercializing, researching, and developing pharmaceutical technologies including:

Small molecule pharmaceuticals
Biopharmaceuticals
Central and peripheral pain therapeutics
Pharmaceutical formulations

Drug combinations
Pharmaceutical delivery methods
Immuno-Oncology Indications
Antiviral drug screening

Enzyme mimetics
New Salts and Polymorphs
Cardiovascular Indications

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Gemany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

Pharmaceutical Patent Attorneys - Pharmaceutical Patent Preparation & Prosecution Lawyer - Pharmaceutical Intellectual Property Litigation Law Firm - San Francisco Biopharmaceutical IP - New Jersey Pharmaceutical Lawyers - Cambridge Pharmaceutical Counsel